Featured publications

• High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: a multicenter cohort from the MelaNostrum Consortium

  Pellegrini, C; Cardelli, L; Ghiorzo, P; Pastorino, L; Potrony, M;

  (...)

  Calista, D; Nagore, E; Puig, S; Landi, MT; Fargnoli, MC.

  See complete list of authors

  Reference:

  Journal Of The European Academy Of Dermatology And Venereology 2023.

• Prognostic role of microsatellites in melanoma and implications in the AJCC classification system: a cohort study

  Riquelme-Mc Loughlin, C; Sandoval-Clavijo, A; de Tord, MB; Boada, A; Alos, L;

  (...)

  Carrera, C; Malvehy, J; Puig, S; Toll, A; Podlipnik, S.

  See complete list of authors

  Reference:

  Journal Of The American Academy Of Dermatology 2023.

• Analysis of dermoscopic changes of blue nevi on digital follow-up: a 21-year retrospective cohort study

  Alamon-Reig, F; Combalia, M; Albero-González, R; Alòs, L; Carrera, C;

  Puig-Butillé, JA; Villanueva-Cañas, JL; Puig, S; Malvehy, J; Podlipnik, S.

  Reference:

  Journal Of The American Academy Of Dermatology 2023.

• A reinforcement learning model for AI-based decision support in skin cancer

  Barata, C; Rotemberg, V; Codella, NCF; Tschandl, P; Rinner, C;

  (...)

  Puig, S; Rosendahl, C; Soyer, HP; Zalaudek, I; Kittler, H.

  See complete list of authors

  Reference:

  Nature Medicine 2023.

• Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study

  Marti-Marti, I; Podlipnik, S; Cañueto, J; Ferrándiz-Pulido, C; Deza, G;

  (...)

  Moreno-Arrones, OM; Abril-Pérez, C; Tomás-Velázquez, A; Sandoval-Clavijo, A; Toll, A.

  See complete list of authors

  Reference:

  Journal Of The American Academy Of Dermatology 2023.

• The MC1R r allele does not increase melanoma risk in MITF E318K carriers

  Wallingford, CK; Demeshko, A; Krishnakripa, AK; Smit, DJ; Duffy, DL;

  (...)

  Law, MH; Cust, AE; Potrony, M; Soyer, HP; McInerney-Leo, AM.

  See complete list of authors

  Reference:

  British Journal Of Dermatology 2023.

• Clinical characterization and treatment outcomes of follicular cutaneous immune-related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study

  Freites-Martinez, A; Nikolaou, V; Lallas, K; Carrera, C; Sollena, P;

  (...)

  Fattore, D; Fabbrocini, G; Segura, S; Riganti, J; Sibaud, V.

  See complete list of authors

  Reference:

  Journal Of The American Academy Of Dermatology 2023.

• Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

  Chesney, JA; Ribas, A; Long, G; Kirkwood, JM; Dummer, R;

  (...)

  Chan, EL; Bhatta, S; Gansert, J; Hodi, FS; Gogas, H.

  See complete list of authors

  Reference:

  Journal Of Clinical Oncology 2023.

• Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test

  Jarell, A; Gastman, BR; Dillon, LD; Hsueh, EC; Podlipnik, S;

  (...)

  Quick, AP; Martin, BJ; Kurley, SJ; Goldberg, MS; Puig, S.

  See complete list of authors

  Reference:

  Journal Of The American Academy Of Dermatology 2022.

• Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

  Eggermont, Alexander M M; Blank, Christian U; Mandala, Mario; Long, Georgina, V; Atkinson, Victoria G;

  (...)

  Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline.

  See complete list of authors

  Reference:

  Lancet Oncology 2021.